Teva Pharmaceutical Industries Ltd. (TEVA)
38.53
-0.72
(-1.83%)
USD |
NYSE |
Sep 16, 16:00
38.53
0.00 (0.00%)
After-Hours: 20:00
Teva Pharmaceutical Industries Market Cap : 44.89B for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 16, 2026 | 44.89B |
| September 15, 2026 | 45.73B |
| September 14, 2026 | 45.11B |
| September 11, 2026 | 43.10B |
| September 10, 2026 | 42.35B |
| September 09, 2026 | 42.93B |
| September 08, 2026 | 42.83B |
| September 04, 2026 | 42.36B |
| September 03, 2026 | 42.66B |
| September 02, 2026 | 43.68B |
| September 01, 2026 | 42.16B |
| August 31, 2026 | 42.00B |
| August 28, 2026 | 42.45B |
| August 27, 2026 | 43.83B |
| August 26, 2026 | 44.18B |
| August 25, 2026 | 44.39B |
| August 24, 2026 | 43.02B |
| August 21, 2026 | 43.50B |
| August 20, 2026 | 42.88B |
| August 19, 2026 | 43.65B |
| August 18, 2026 | 42.62B |
| August 17, 2026 | 42.48B |
| August 14, 2026 | 42.84B |
| August 13, 2026 | 42.55B |
| August 12, 2026 | 42.80B |
| Date | Value |
|---|---|
| August 11, 2026 | 42.50B |
| August 10, 2026 | 42.10B |
| August 07, 2026 | 41.19B |
| August 06, 2026 | 40.55B |
| August 05, 2026 | 40.45B |
| August 04, 2026 | 40.11B |
| August 03, 2026 | 40.15B |
| July 31, 2026 | 40.79B |
| July 30, 2026 | 41.25B |
| July 29, 2026 | 40.44B |
| July 28, 2026 | 36.90B |
| July 27, 2026 | 36.18B |
| July 24, 2026 | 35.86B |
| July 23, 2026 | 36.29B |
| July 22, 2026 | 35.09B |
| July 21, 2026 | 36.49B |
| July 20, 2026 | 36.08B |
| July 17, 2026 | 37.28B |
| July 16, 2026 | 37.50B |
| July 15, 2026 | 36.74B |
| July 14, 2026 | 37.04B |
| July 13, 2026 | 37.46B |
| July 10, 2026 | 38.35B |
| July 09, 2026 | 38.53B |
| July 08, 2026 | 38.69B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.071T |
| Bristol Myers Squibb Co. | 129.93B |
| RedHill Biopharma Ltd. | 2.801M |
| Johnson & Johnson | 643.67B |
| MediWound Ltd. | 170.67M |
Market Cap Related Metrics
| PE Ratio | 64.79 |
| PS Ratio | 2.584 |
| Price to Book Value | 5.790 |
| Price to Free Cash Flow | 30.70 |
| Price | 38.53 |
| Earnings Yield | 1.54% |
| Operating PE Ratio | 13.75 |
| Normalized PE Ratio | 24.27 |